VRCA · Healthcare · $76M
Pre-market $4.45-0.22%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“매출은 2분기 590만 달러로 전 분기 500만 달러에서 회복됐고, 특히 미국 YCANTH 제품 매출은 18.7%, 사용된 도포기 수는 28%”
In the company's words · 2026 2분기 earnings call